NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Shanghai OuDaXin New Material Technology Center? Mail in a sample (US only) and let us test it.

Test my supply
+9 more ↓
62%
Finnrick rating
#416 of 500 ranked vendors
42 of 58 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Shanghai OuDaXin New Material Technology Center has its stronger purity-focused evidence in Tirzepatide and Retatrutide, where recent passing results temper earlier identity and fill failures. Tesamorelin is more volatile and BPC-157 is thin and weak, with sparse batch IDs making consistency harder to read.

methodology →
vendor intelligence report
Vendor Intelligence Report: Shanghai OuDaXin New Material Technology Center

We investigated who actually operates Shanghai OuDaXin New Material Technology Center — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

22 pages7 risk factors assessed12 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.28
78%
24
2
Retatrutide
$0.71
76%
15
3
Ipamorelin
$0.72
69%
4
4
Tesamorelin
$1.17
55%
9
5
BPC-157
-
49%
3
6
CJC-1295
$1.90
35%
3
7
ARA-290
$0.75
-
0
8
DSIP
$1.64
-
0
9
Epithalon
$0.32
-
0
10
GHK-Cu
-
-
0
11
Glutathione
$0.01
-
0
12
KPV
$0.70
-
0
13
Melanotan II
$0.62
-
0
14
Oxytocin
$1.24
-
0
15
PT-141
$0.68
-
0
16
TB-500
$1.68
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%25 Nov 2025: 59%25 Nov 2025: 58%25 Nov 2025: 57%25 Nov 2025: 56%6 Dec 2025: 56%6 Dec 2025: 55%6 Dec 2025: 55%6 Dec 2025: 54%10 Dec 2025: 52%16 Dec 2025: 51%17 Dec 2025: 51%18 Dec 2025: 50%22 Dec 2025: 50%29 Dec 2025: 50%29 Dec 2025: 51%29 Dec 2025: 51%29 Dec 2025: 51%1 Jan 2026: 51%1 Jan 2026: 52%7 Jan 2026: 52%7 Jan 2026: 52%7 Jan 2026: 53%7 Jan 2026: 53%9 Jan 2026: 53%15 Jan 2026: 54%15 Jan 2026: 53%19 Jan 2026: 54%26 Jan 2026: 54%4 Feb 2026: 55%4 Feb 2026: 55%10 Feb 2026: 55%10 Feb 2026: 56%20 Feb 2026: 57%20 Feb 2026: 57%26 Feb 2026: 59%10 Mar 2026: 59%23 Apr 2026: 59%28 Oct 2026: 59%5 Nov 2026: 61%5 Nov 2026: 61%17 Nov 2026: current 62%59%59%62%Nov 25Nov 26
Peptide testing

Ordered peptides from Shanghai OuDaXin New Material Technology Center? Mail in a sample (US only) and let us test it.

Test my supply
Shanghai OuDaXin New Material Technology Center test history
COA-backed lab tests
1-10 of 58

About Shanghai OuDaXin New Material Technology Center test results from Finnrick

Shanghai OuDaXin New Material Technology Center is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 58 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Shanghai OuDaXin New Material Technology Center peptides in this dataset are BPC-157 (3 tests), CJC-1295 (3 tests) and Ipamorelin (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 58 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Shanghai OuDaXin New Material Technology Center? Mail in a sample (US only) and let us test it.

Test my supply